Is Gonadotropin chorionic approved by the US FDA?

Drugs@FDA lists 12 application product lines for Gonadotropin chorionic, including CHORIONIC GONADOTROPIN (Prescription); CHORIONIC GONADOTROPIN (Prescription); PREGNYL (Prescription); CHORIONIC GONADOTROPIN (Discontinued); CHORIONIC GONADOTROPIN (Discontinued).

Are there safety signals or safety updates for Gonadotropin chorionic?

US FDA: 1 entry (latest 2023-03-02).

Active substance

Gonadotropin chorionic

US FDA 12
Safety 1

Open in the medicines table

US FDA United States — FDA approvals (Drugs@FDA)

Product	Strength	Form · route	Applicant	Status	First approved
CHORIONIC GONADOTROPIN	10,000 UNITS/VIAL	injectable · injection	FRESENIUS KABI USA	Prescription	5 Mar 1973
CHORIONIC GONADOTROPIN	5,000 UNITS/VIAL; 10,000 UNITS/VIAL	injectable · injection	FERRING	Prescription	15 Jan 1974
PREGNYL	10,000 UNITS/VIAL	injectable · injection	ORGANON USA LLC	Prescription	20 Oct 1976
CHORIONIC GONADOTROPIN	5,000 UNITS/VIAL; 20,000 UNITS/VIAL; 15,000 UNITS/VIAL	injectable · injection	FRESENIUS KABI USA	Discontinued	5 Mar 1973
CHORIONIC GONADOTROPIN	20,000 UNITS/VIAL; 2,000 UNITS/VIAL; 15,000 UNITS/VIAL	injectable · injection	FERRING	Discontinued	15 Jan 1974
CHORIONIC GONADOTROPIN	5,000 UNITS/VIAL; 10,000 UNITS/VIAL	injectable · injection	BEL MAR	Discontinued	26 Mar 1974
A.P.L.	5,000 UNITS/VIAL; 10,000 UNITS/VIAL; 20,000 UNITS/VIAL	injectable · injection	FERRING	Discontinued	13 Dec 1974
CHORIONIC GONADOTROPIN	5,000 UNITS/VIAL	injectable · injection	QUAD PHARMS	Discontinued
CHORIONIC GONADOTROPIN	5,000 UNITS/VIAL	injectable · injection	QUAD PHARMS	Discontinued
CHORIONIC GONADOTROPIN	10,000 UNITS/VIAL	injectable · injection	QUAD PHARMS	Discontinued
CHORIONIC GONADOTROPIN	10,000 UNITS/VIAL	injectable · injection	QUAD PHARMS	Discontinued
CHORIONIC GONADOTROPIN	20,000 UNITS/VIAL	injectable · injection	QUAD PHARMS	Discontinued

Safety signals and safety-related labeling changes

US FDA 2 Mar 2023 PREGNYL — safety-related labeling change
Labeling sections changed: Contraindications; Warnings and Precautions; Adverse Reactions; Use in Specific Populations

All safety entries for gonadotropin chorionic →

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.